CBDOilReviews.com

Category: Investments

  • CBD Training Institute: Become a Legit Cannabidiol Hemp Expert Program?

    CBD Training Institute: Become a Legit Cannabidiol Hemp Expert Program?

    While the health market of CBD has been suppressed for years, it is just about to become the most significant business opportunity in the USA. Recently, President Trump signed a landmark $867 billion farm bill that opened the $22 billion expected floodgates of the CBD industry.

    The CBD Training Institute is one of the greatest players in the U.S. CBD industry. This academy has created numerous training programs meant to help people do business and profit from the rewarding CBD industry. It takes charge of training interested entrepreneurs or industry professionals and gives them a platform to network with other players for continuous growth.

    How the CBD Training Institute Operates

    Each of the institute’s co-founders has their own story on struggles with conventional medicine in the treatment of anxiety, pain, seizures, and cancer. The CBD coaches were inspired by the need to solve the knowledge gap there was (or still is) between CBD products sold in the market and those who need CBD most.

    The CBD Training Institute either provides the latest information on the rapidly changing CBD industry to interested parties in an on-demand or live format. People in need of direct interaction with the institute’s instructors can opt for the Live training. Here, they get a chance to ask questions directly and get answers immediately. The On-demand format is good for people who would love to carry out the training in a compressed format and on their own pace.

    Both the Live and on-demand learning options cover the same material and are made up of topics like efficacy, dosage, uses of CBD, and methods of CBD delivery.

    What Benefits Does the CBD Training Institute Offer?

    People who join the global network of certified CBD professionals stand to benefit from the following.

    1. Participating In Exclusive, Insightful Teleconferences and Webinars

    Trainees get the chance to interact with experts, colleagues, industry leaders, and marketing gurus to get hands-on and proven strategies. From the webinars and teleconferences, people acquire proven tips and ideas on how to make it in the CBD industry. Tips include how to get new clients and add value to them.

    2. Enhanced Market Credibility

    Certified professionals at The CBD Training Institute train people to attract new opportunities. Trainees hence get the chance to enjoy more credibility in the market globally. The professional’ network and caliber give the qualifications of trainees credence.

    3. Exchanging Valuable Guidance with Fellow Members

    The CBD Training Institute includes a peer-coaching program where members can make beneficial connections free of charge.

    4. Ideas and Strategies Access

    The CBD Training Institute has an exclusive CBD Power Tool Library where members get the chance to give clients customized power reading tools regarding CBD. These power tools are scientifically backed and have been reviewed by the institute’s Chief Medical Information Officer. Not only do the power tools play an educational role, but also do they improve a member’s credibility to clients.

    5. Referral Fees

    The CBD Training Institute’s members get 10% to 20% of all fees generated from referrals. This makes members part of a big global network of well-certified professionals in the industry and acts as a perfect income supplement.

    Additional member benefits:

    • Getting customer referrals to grow business
    • Members get a chance to participate in the institute’s award programs
    • Access to choose online training events freely
    • Members get a discount of 25% on all academy CBD training courses
    • Access to industry vendors through the institute’s match marking services
    • Getting answers to questions from the institute’s medical and business advisory members
    • Members become eligible to participate in the institute’s affiliate program and get money for referring others to training
    • A high level of listing in the institute’s global industry’s directory freely. Nonmembers pay $299 monthly.

    Member Requirements

    Members of the Global CBD professional networks are required to abide by the institute’s code of ethics. A commitment to continued education is required, alongside a fair play and offering support to other members. Network members are also required to promote membership and marketing material designation on the institute’s website.

    Is The CBD Training Institute Membership Worth?

    If you are looking to grow in the cannabis industry, you need to learn its ins and outs. The CBD Training Institute offers you not only a learning platform but also a chance to network with bigger industry players, and better-growing ground. A huge number of the institute’s members find the academy beneficial and a great platform to thrive in business. With the vast training resources, experienced tutors, and learning flexibility, The CBD Training Institute will benefit you dearly.

  • The Cannabis Software: Profitable Marijuana Stock Investing Opportunity?

    The Cannabis Software: Profitable Marijuana Stock Investing Opportunity?

    Cannabidiol (CBD) has become a solution for men and women who are looking to alleviate anxiety, stress, anxiety, muscle and joint pain, and a range of other issues in a natural manner. Though CBD products may be a positive solution for these issues, many are now turning to CBD for other purposes – such as stocks. That’s right, an investment opportunity. Questionable? Indeed. One platform that offers CBD as an investment opportunity is Cannabis Software. Before you go and sign up though, here is what you need to know:

    What is Cannabis Software?

    Cannabis Software is a platform that describes itself as “a powerful automated trading software that lets you trade cannabis stocks with ease. Available in both automated and manual models, this app pinpoints lucrative trading opportunities in the markets and makes profitable trades with very high accuracy.” Essentially, those who use this platform can use the platform and by just letting it do it’s job, the platform will decide which investments to make. And because the platform is so intelligent, it is able to pinpoint those money-making opportunities. In turn, users may be able to earn money effortlessly. It sounds too simple to be true – and it may just be.

    $7,000 a Day?

    It seems to get even better. The platform presents on its website that “Cannabis Software Users are Making more than $7,000 a Day!” And what can one do with this kind of money? Well, the platform states that users can take a vacation, purchase a luxury vehicle, or get all of the latest gadgets. Essentially, the options are endless. Whether one chooses to rely on such states is another thing and it may just be preferable to be as wary as possible.

    Jump in Now?

    The platform also explains that the CBD industry is hot and is still in its infancy, making it the ideal time to jump in. As the brand explains, “Stop hesitating and losing out on the chance to make real profits. If you would have invested in Microsoft in 1986 and bought 100 shares then at $21 each, today these shares would be worth more than $750,000. With cannabis stock prices growing 10 times faster, this $750,000 would be worth $7,500,000.”

    This statement has many issues. First, users cannot generally invest in “cannabis,” rather, investments are made in companies. Second, it is highly unlikely that cannabis and Microsoft are comparable investments. Microsoft was one of the first technology companies, while any cannabis investment is in an age-old and already common product. In sum, there are many considerations to take into account before deciding to invest. These are just bits of “food for thought” so to say, so that users can make the right decision.

    The Cannabis Software Summary

    Overall, one’s decision to invest – or not to invest – in Cannabis Software is one that should be taken with care. The platform features many markers that would make anyone skeptical. It is best to vet an investment opportunity, to learn as much as possible, and to do one’s research before making a decision. Keep in mind that this post is not investment advice in any form.

  • New $75 Million Investment For Cannabis Startup Caliva Gains Support From Yahoo CEO And Football Legend Joe Montana

    New $75 Million Investment For Cannabis Startup Caliva Gains Support From Yahoo CEO And Football Legend Joe Montana

    Caliva is a local cannabis startup in San Jose that is looking to get their brand off the ground, and they’ve managed to host a funding round that had many interesting contributors. Between Yahoo CEO Carol Bartz, football superstar Joe Montana, and others, the new company brought in a whopping $75 million. Despite the many different opinions on cannabis, it is clear that the ones in favor of its use are a varied bunch.

    The company’s goal is to expand the products that it presently holds, which are referred to as a “war chest.” They’ll also use the funding in their work to market to cannabis users in California, using a combination of sales to distributors, companies that sell directly to customers, and brick and mortar stores. Even though the market didn’t have the momentum that they would’ve desired with the newly implemented state regulations, Caliva managed to thrive with a 350% increase in revenue. They also increased their staff to 440 members.

    Montana, who is already a general partner with Liquid 2 Ventures, has some experience in cannabis investing already, after investing in a 2017 seed round for Herb. Considering the substantial benefits for athletes in cannabis, like the reduction in pain and the soothing of inflamed muscles, it is common for former players to take part in the cannabis business, especially with CBD.

    When speaking on his interest in this industry, Montana commented,

    “As an investor and supporter, it is my opinion that Caliva’s strong management team will successfully develop and bring to market quality health and wellness products that can provide relief to many people and can make a serious impact on opioid use or addiction.”

    Right now, Caliva already has a retail location, but they have more of a standing than just offering their remedies alone. Along with many of the common brands in the marketplace, Caliva sells their products too. They even have a distribution center nearby.

    Bartz, who has expressed her intention to join the board for Caliva, said, “I know great opportunities when I see them.”

  • Cannabis Trader: Legit Medical Marijuana Shares Online Trading Platform?

    Cannabis Trader: Legit Medical Marijuana Shares Online Trading Platform?

    Canada has legalized cannabis and some states in the United States have also taken steps as well. Of course, there are businesses that are capitalizing on the opportunity and one of them is Cannabis Trader, which describes cannabis as “among the most rapidly growing industries for investors to put their capital in and things are only going to get even more explosive.”

    In an effort to highlight just how “explosive,” things are getting, the platform provides a chart with an arrow trending upward and enlarged leaves, one for each year from 2016 to 2022. Not surprisingly, the left of the chart is unmarked. The big change is whether this type of platform is the path to, as the brand explains, “start changing your life today.” Likely not.

    About Cannabis Trader and Unsubstantiated Claims

    One of the most irksome features of the platform is that it features unsubstantiated claims. For example, the platform states “Shares of companies linked to cannabis for medicinal use have increased by 60% in just the last month. A trend over ten times higher than the growth of giants like Amazon and Apple. Experts see the value of these companies reaching 1000% over the next 3 years.” There is no information to support such a position, making the claim dubious and difficult to believe. It also isn’t usually a good idea to place one’s hopes on a platform that doesn’t provide any insight.

    Profit from CBD Investment?

    The platform makes the claim that “cannabis for medicinal use, which has a growth trend 10 times higher, could yield a profit of 80 million dollars.” Again, like the platform’s other claims, there is nothing that shows support for such a statement. Those who are looking to invest should take care that they are making the right decision for their needs. Here, it is challenging to determine whether one is making the right decision, especially in light of the fact that one would essentially be putting money into a very questionable investment.

    “Certified” Online Trading Platform?

    Cannabis Trader also presents itself as a “certified” online trading platform. However, the platform does not identify who certified it, what kind of certification is necessary, and what the certification means. Essentially, this suggests that the platform is presenting empty words without providing users with any substantive information that can help them to make an informed decision. Again, it’s difficult to get behind something that isn’t clear and informative.

    Hefty Minimum Deposit

    Another point to note is that anyone looking to join has to pay a hefty minimum deposit, which is $250. This is a significant fee to participate in a trading platform, especially when many other platforms are much lower priced.

    Cannabis Trader Summary

    Overall, anyone interested in the CBD field should take heed of the “promotions” out there, especially where there is very little to no information to support their claims. The best decision that one can make is an informed one. Therefore, keep an eye out for the positive projects and stay away from those that seem subpar.

  • CBD Manufacturer Cure Based Development (cbdMD) Acquired By Level Brands, Valued At $120 Million

    CBD Manufacturer Cure Based Development (cbdMD) Acquired By Level Brands, Valued At $120 Million

    As December 2018 brought forth the legalization of hemp in the United states, one CBD company has already been acquired by a firm that focuses on improving the branding of remedies. The CBD company, Cure Based Development, was involved in an all-stock transaction that had a value of $120 million, with the expectation that it would result in $300 million in revenue by 2024.

    The firm that took over the purchase, Level Brands, is a publicly-traded company that already has a substantial portfolio that includes Kathy Ireland as one of their brands. They plan to offer 15.3 million common stock shares, which they will follow with another 15.3 million common stock shares once the $300 million goal is achieved.

    Right now, there will not be much change to the way that Cure Based Development functions, which will still be cbdMD. The founder, Scott Coffman, will take on the role of the CEO, while functioning as a subsidiary of Level Brands. The deal was made official the day after the 2018 Farm Bill was signed into law.

    The Farm Bill is necessary for the functioning of this brand, considering that the law made it possible to delist CBD as a Schedule 1 controlled substance. With this freedom, hemp entrepreneurs got to enjoy a world of new opportunities. However, despite the new surge that is expected to come, the CEO of Level brands is not worried about the potential suffering that the Kathy Ireland CBD product line could take.

    CEO Martin Sumichrast said, “We think that the market obviously is big enough out there to really build both product lines up.”

  • Alex Koyfman’s Perfect $1 Pot Stock: Cannabis Company More Powerful Than the Fed Govt?

    Alex Koyfman’s Perfect $1 Pot Stock: Cannabis Company More Powerful Than the Fed Govt?

    Cannabis industry analyst Alex Koyfman recently launched an advertising campaign centered on a simple topic: there’s a “Perfect $1 Pot Stock” made by a company that’s “more powerful than the federal government”.

    Of course, Koyfman won’t tell you the name of this company until you sign up for high high-priced subscription service. That subscription is priced at $999.

    If you don’t want to pay $999 for an email newsletter but still want to identify this $1 pot stock, then we want to help. Travis Johnson over at Stock Gumshoe recently completed an investigation into Koyfman’s fabled $1 pot stock:

    “This ad from Alex Koyfman is really bursting with hyperbole, and readers have been asking about it for close to a month now… so let’s see if we can get you some answers.”

    Let’s take a look at what Stock Gumshoe found, including whether or not the perfect $1 pot stock really exists.

    What is the $1 Pot Stock?

    Koyfman’s advertisements for his $999 subscription service quickly become hyperbolic. His advertisements feature quotes like:

    “If I had to bet my entire life savings on just one stock….this is easily the one.”

    Meanwhile, prospective subscribers are greeted with an “order” button featuring the quote, “Yes, I want to get rich.”

    Amidst all of this hyperbole, it’s easy to assume the $1 pot stock doesn’t exist, or that Koyfman is exaggerating.

    However, as revealed by Travis Johnson at Stock Gumshoe, the $1 pot stock does indeed exist – and it’s sitting at around the same price it was sitting at in December.

    Johnson analyzed quotes from Koyfman to reveal the $1 pot stock without actually signing up for the $999 subscription service.

    Clues Behind the $1 Pot Stock

    First, Koyfman reveals a number of clues about his fabled $1 pot stock. He claims it’s on the verge of disrupting a $146 billion global market, for example, and describes how the company “recently signed a massive three-year $54 million contract.”

    He goes on to explain that this company has signed “dozens of deals” in countries like Canada, Jamaica, and Italy, as well as in U.S. states like Nevada, Washington, and California. Some of the specific deals included an $11.4 million per year deal guaranteed for the next three years.

    Then, Koyfman doubles down on his hype, inexplicably stating that the company’s partnerships will 10x its revenue within the next few years:

    “Based on all current partnerships, I fully expect this company to make up to 10 times more than that – per year.”

    The hyperbole doesn’t stop there. Koyfman then goes on to describe how his $1 company “is more powerful than the federal government”:

    “It effectively has more power than the U.S. government, twice the knowledge, and most importantly, it’s flush with cash.”

    What does any of this mean? How is any single company more powerful than the federal government? These are all good questions to ask.

    For these reasons, the company has been able to land massive deals “that federal institutions simply can’t take part in.” Some of the deals mentioned by Koyfman include a 1,000 acre land deal in Nevada and 40,000 square feet of indoor growing facilities in California.

    Essentially, Koyfman is throwing a bunch of large and impressive numbers at you to dazzle you and convince you to sign up for his $999 newsletter.

    Koyfman’s $1 Pot Stock is Crop Infrastructure Corp (CROP)

    According to Stock Gumshoe, Koyfman’s mysterious stock has to be Crop Infrastructure Corp (CROP), a CSE-listed company that functions as like a financier for the pot industry.

    CROP fills a unique niche in the pot space. Today, America’s cannabis companies cannot access traditional banking and lending services because the industry continues to be largely illegal nationwide. Because of this, cannabis companies do not have easy access to bank loans, mortgages, and regular financing.

    CROP is one company that has emerged to fill that niche. Today, the company fills that niche by backing land acquisition or property development in exchange for some return from the cannabis company – like equity, rent, or economic exposure to the underlying business.

    In other words, Crop Infrastructure Corp works in a similar way to Innovative Industrial Properties (IIPR), which is an REIT focused specifically on marijuana cultivation. The company buys properties from or for medical marijuana growers, then leases the properties back on long-term leases. This allows growers to access financing without relying on traditional banks.

    CROP, however, is not an REIT: it’s mostly a land-based financier. To date, the company appears to have signed a number of effective partnerships, although most of the growth is fueled by the company’s effective promotional and marketing spending.

    What’s the Catch with Crop Infrastructure Corp?

    As pointed out by Stock Gumshoe, there are some areas of concern with Crop Infrastructure Corp:

    “Well, the primary “dislike” for me is the lack of detailed disclosure of their deals, and the massive dilution.”

    The dilution could be an issue for stockholders in the future:

    “Like most financiers who don’t have access to the debt markets, including IIPR, they have to issue new shares to fund their deals…. but since they’re brand new and don’t have any revenue-generating assets yet (let alone income), the share count quickly balloons because they’re selling shares for pennies to raise money for both operating costs and new projects.”

    The company currently has about 133 million shares outstanding. Crop Infrastructure has filed to bring that up to 150 million. Back in May, the company had just 80 million outstanding shares. By August, the number had risen to 110 million.

    “So the capital raises have been steady in their young life as an operating company (they effectively went public late in 2017, through a reverse merger, but didn’t really trade publicly until this past summer).”

    Should You Buy Koyfman’s $1 Marijuana Stock

    Crop Infrastructure Corp is a small player compared to larger, better-established competitors like Innovative Industrial Properties (IIPR). The company has signed a number of promising deals. However, the returns have been minimal thus far. Much of the hype surrounding Crop Infrastructure Corp seems to be fueled by effective marketing.

    Here’s how Stock Gumshoe sums up the issue with Crop Infrastructure:

    “Frankly, when you read the background story a little bit and see that this is a company run by an investor relations/PR guy, with a person from Stockhouse on the board, you might begin to think of it as a company that specializes mostly in convincing investors that it’s an exciting company. It doesn’t specialize in detailing how they’ll actually make money… which might be intentional, if they’re spending as much on operating the company (even without employees) as they are on the actual investments that are supposed to generate revenue at some future point.”

    Ultimately, Koyfman’s $1 marijuana stock pick is an equity-based financier that may offer a high-risk, high-reward investment opportunity to certain investors.

    You can read a more detailed summary of Koyfman’s Crop Infrastructure pick at Stock Gumshoe here.

  • 90 Day CBD Challenge: Chris Record’s Hempworx MLM Cannabidiol Product Marketing System?

    90 Day CBD Challenge: Chris Record’s Hempworx MLM Cannabidiol Product Marketing System?

    The recent passing of the Farm Bill and the increasing attention towards CBD has elicited a new challenge in the industry – the 90-Day CBD Challenge. The Challenge has been advertised through YouTube videos and other media, but what is it? Why is it important? What can CBD do?

    Why CBD Oil?

    As said above, CBD is growing in popularity, but why? Scientific research shows that it has a significant effect on the body, helping with issues concerning physical pain and mental stress. There is even been a variation approved by the FDA for the treatment of two types of epilepsy. Multiple reports are available to back up these claims, though there is still a lot of research left to do on it.

    Why Does the Public Have A Problem With CBD?

    One of the main causes of issue with CBD is that people tend to link it directly with THC, which is a chemical that also comes from cannabis, but it causes a psychotropic effect, making the user feel “high.” However, the public has been greatly misinformed on this account, because hemp-based CBD oil doesn’t create that sensation at all. In fact, even with trace amounts, consumers just get the therapeutic benefits, which is why it is not illegal to use.

    Some sources predict that the CBD industry will see $22 billion in sales in the next three years, though it is possible that these projections are extremely low. Considering that it looks like the industry is on the cusp of something massive, this is the time to get invested.

    The official website suggests,

    “Figure out a way to position yourself in front of this massive shift in the market, and when the 2018 Farm Bill passes in the US (which is assumed to be any day), this will explode the CBD Oil market.”

    What Does Legalization Mean For Profits?

    Right now, CBD is not quite mainstream, and the way it can be advertised is minimal at best. However, any entrepreneur would be foolish to leave this opportunity to spoil. The creators of the 90-day CBD challenge says that there are already many people flocking to sell CBD, and they have three suggestions that could help these ambitious people:

    • Sell CBD oil on their own
    • Create a sales team to sell CBD
    • Research stocks in CBD

    Though the creator seems to taunt that they already know where to invest, they also advise to keep an eye out for Facebook and Instagram. Though these social media websites do not presently allow for the advertising of products, those rules could become more lenient as CBD becomes a mainstream option. In fact, Facebook has already allegedly said that they will allow CBD-related pages to come up in searches, which is a drastically different policy than what they currently hold. However, the key is to avoid claims of what CBD can do, and just focus on advertising the product itself.

    What The 90-Day CBD Challenge Entails

    The creators of the challenge reveal that they have already established a partnership with a “biz-opp” called HempWorx. For them, this challenge is more of an “affiliate offer” than anything else. Explaining, they elaborate what HempWorx actually offers.

    The challenge states,

    “HempWorx is a hybrid of a Unilevel Comp Plan and a Binary Comp Plan. The Binary side means you build 2 legs and you try to balance them evenly. People enroll on the left, people enroll on the right, and so on. Basically, like a network marketing biz opp. And if you follow me you know that I’m not interested in stuff like that right now. But here is the deal. The other part of the compensation plan is “Unilevel.” Which in simple terms means you do not need to build the right leg. You can achieve MOST of the commissions by simply referring people and stacking them all on the left side.”

    Then, they reveal that they have discovered a method of hacking the compensation plan, focusing on the Unilevel option. They claim that these options allow for participants to make plenty of money, effectively creating a pyramid of enrollments and earnings.

    The participant’s responsibility starts by referring members to the challenge, where they will get access to the applicable videos. The recruited members can upgrade to become “Affiliates of the System,” and the entrepreneur that recruits them gets $200 for each new member, along with $up to $40 overrides on each of their sales as well.” Essentially, the participant does nothing more than recruit.

    Watch The Video

    Participation in the CBD challenge will teach users how to set up the CBD business and there is no former experience necessary to do so. Chris Record spoke on behalf of the challenge. Clearly, this opportunity was only just publicized, however, because the video itself has less than 500 views as of 10:00pm on January 9th, despite being released on November 29th, 2018.

  • Green Leaf Fortune: Legit Program To Profit From Cannabis Legalization?

    Green Leaf Fortune: Legit Program To Profit From Cannabis Legalization?

    Ever wonder how contract for differences (CFD) work? Not sure what the difference between CFD and stocks are? As defined by Investopedia, a contract for differences serves as a futures contract between a buyer and seller in which the difference (loss or gain) is paid in cash. What makes CFDs a preferable investment is the high leverage associated, which ranges between 2 and 20%. Since investors do not own the securities themselves, additional fees are not required as well.

    All this being said, in recent times CFDs have been promoted in relation to the cannabis industry. As we’ve all seen, US states and other parts of the world have been actively assessing the potential cannabis has on one’s health. Since it is a relatively new market with a lot of room for growth, investing in said market might be a great move, however, not all CFDs are created equally.

    The following review will look at Green Leaf Fortune, a platform that claims to help investors “become rich” in a short time span. The purpose is to see whether the advertised CFD is at all worth it.

    What Is Green Leaf Fortune?

    Green Leaf Fortune claims to help investors make significant amounts of money through the aforementioned tool called CFD. Their main focus is to introduce investors to the cannabis market – in which gains can be made because of its infancy stages and popularity.

    What Is flawed About Green Leaf Fortune?

    Upon visiting the official website, one might assume that Green Leaf Fortune specializes in the financial sector, especially bearing in mind the level of knowledge they appear to have in CFDs and stocks. However, this is not the case.

    As seen at the very bottom of the page, Green Leaf Fortune, “is a technology, marketing and advertising service. Green Leaf Fortune is not a financial services firm and does not operate as a financial services firm.” This is concerning, as it is not clear what type of CFD trading is taking place or whom is namely in charge.

    Next, regardless of the investment strategy in place, professionalism always holds. Therefore, evidence shown under “Social Proof,” is a clear indicator of a money-grabbing scheme because follow-ups are usually done via e-mail or phone call, and not necessarily via text messages.

    When considering the overall affordability of this service, there appears to be no details or options present. Investors are simply requested to create and finalize their account and start investing. Normally, such services do not come free, hence, the fact that no information whatsoever has been provided makes Green Leaf Fortune all the more concerning.

    As much as legalization of marijuana is important, the fact that Green Leaf Fortune failed to provide evidence of cannabis firms growing makes it doubtful altogether because investing requires a lot of research and isn’t something that is done simply by word of mouth.

    Green Leaf Fortune Final Thoughts

    Based on the analysis above, it is clear that Green Leaf Fortune is not a credible source for CFD investing. The lack of sound evidence, and complete information – whether it be price, investment or contact wise – makes it appear as a potential scheme that may result in losses. Also, Green Leaf Fortune serving as simply an “advertiser” makes the entire endeavor quite questionable – possibly one where money should not be invested!

  • Marijuana Investment Symposium: Matt Badiali’s Real Wealth Strategist for Cannabis Stocks?

    Marijuana Investment Symposium: Matt Badiali’s Real Wealth Strategist for Cannabis Stocks?

    There is no doubt about it; marijuana is gaining favor across the board. Before too long, every state, from California to New York, will legalize marijuana. The health benefits are starting to trickle in as new tests are conducted every single day.

    Right now, there is an unprecedented opportunity for you to earn money investing in marijuana stocks. But you have to hurry and get in on the action before marijuana goes mainstream. With nearly 92% of Americans demanding this remarkable plant to be legalized, it is no longer a matter of if, but when. And if you act now, you could turn $50 into $2,000 or more as the marijuana stocks skyrocket to over 4,067%.

    Want to know which stocks to get in order to be ahead of the game? Look no further than Real Wealth Strategist. Real Wealth Strategist will show you not only which marijuana stocks to claim but also let you in on a Canadian mining company that is sitting on a copper and gold deposit. You will also get insider information on which metals will show 3,000% gains in the coming months. Are you ready to sign up yet?

    The Company: Real Wealth Strategist

    Real Wealth Strategist is a newsletter that is brought to you by Banyan Hill Publishing. Banyan Hill Publishing is a financial advisor company that educates people on different stocks and investments to secure their financial futures.

    Leading the charge for Real Wealth Strategist newsletter is Matt Badiali. According to Banyan Hill Publishing, Mr. Badiali is a world traveler. He likes to see his investments before signing on the dotted line. Prior to becoming a part of Banyan Hill Publishing team, Mr. Badiali was a geologist for a drilling company. Today, he utilizes his knowledge in geological studies and fuses that information with smart investment strategies.

    About The Product

    The Real Wealth Strategist is your ticket to investing wisely. The newsletter is more than just a bunch of charts, and stocks. You will get insider information and logical assessments on why you should invest in the companies listed.

    When you sign up to a premium subscription of Real Wealth Strategist for $79, you get also get several free reports. These reports include information on the marijuana stocks, the mining companies as well as metal and mineral companies to keep an eye on. Plus, you will get The Bauman Letter that offers advice on how to protect your wealth.

    But, Real Wealth Strategist also offers you access to their model portfolio, a beginner’s guide for those new to investing, plus weekly updates. You will also get the added benefit of urgent trade alerts sent via text or email, in addition to private briefings that happen once a month. You are also given the opportunity to sit in on weekly podcasts.

    Of course there is the option of the Deluxe subscription that is $129. But you will only get the free reports without the bonus content like the podcasts or text alerts. The Deluxe does offer Real Wealth Strategist in digital and print form. The last subscription option is the Standard package for $47 which is the free reports and newsletter in digital form only.

    It is important to note that regular membership to Real Wealth Strategist is $97 for the year and The Bauman Letter is $79 a year. Due to this offer signing you up for both, you will have to remember to cancel both products if you no longer want them. Also remember that the service is set to automatically renew.

    If for whatever reason you are not completely satisfied, there is the guarantee of a refund if you contact Banyan Hill Publishing within the first year of your service.

    Is There A Business Opportunity?

    There is no mention of an affiliate program for Banyan Hill Publishing. Although, if you should invest your money remember there is the possibility to make a return on that investment. However, you should treat their financial advice as such and never invest with money you can’t afford to lose.

    Real Wealth Strategist Verdict

    Banyan Hill Publishing has been around for a while. When you look online, you will find both good reviews and bad reviews. The fact is though, Banyan Hill Publishing financial advice should be seen as that and nothing more. Sometimes they will offer you stocks that skyrocket and sometimes their picks will be lemons.

    The point is, before you invest your hard earned money, you should do your own research about the stock Banyan Hill Publishing suggests. You could go as far as speaking with your personal financial advisor before making any major decision.

    As far as the Real Wealth Strategist newsletter is concerned, you may find good tips for investing. The fact that the company offers a 100% refund if you are unsatisfied makes it easy to see what they have to say.

  • Cannabis IPO Insider: National Institute for Cannabis Investors by Money Map Press

    Cannabis IPO Insider: National Institute for Cannabis Investors by Money Map Press

    The National Institute for Cannabis Investors is an organization dedicated to sharing cannabis industry news for investors online. One of the organization’s flagship products is a high-priced email newsletter called Cannabis IPO Insider.

    The National Institute for Cannabis Investors just revealed a new video and landing page designed to convince you to sign up for a paid subscription to Cannabis IPO Insider. The company claims that they’re only giving away 447 new subscriptions to their newsletter. Each annual subscription is priced at $1,950 per year. You receive 2 email newsletters per month featuring the latest news from the cannabis industry, including detailed information about specific cannabis industry IPOs.

    Let’s take a closer look at the landing page and the National Institute for Cannabis Investors subscription to see if it’s worth the high price.

    What is Cannabis IPO Insider?

    The video starts by claiming that 77 ordinary investors have become multimillionaires from making a small investment in the right cannabis stocks.

    “One very famous Canadian business magazine has already found 77 everyday folks who made $1 million or more just in the last few months,” explains the video.

    Like other National Institute for Cannabis Investors videos, the goal is to convince you that anyone – even you – can quickly get rich by investing in the right marijuana companies. A small investment in the right company today can pay off massively in the future. With billion-dollar cannabis IPOs taking place on a monthly basis, there’s never been a better time to invest in cannabis – at least that’s what National Institute for Cannabis Investors claims.

    The video features Mike Ward from the National Institute for Cannabis Investors. It also cites Danny Brody, described as a venture capitalist and cannabis IPO expert.

    The video also has a deadline: January 31.

    Why the January 31 Cannabis Investor Deadline?

    “We can say with absolute certainty that these four companies are set to go public before January 31,”

    explains the video. The video keeps these companies secret until you sign up.

    “Each of these companies is capable of generating between $500 million and $3 billion for investors the day they go public. “That’s a potential $12 billion in new wealth created before January 31.”

    By investing in these companies today, you can get rich quick – at least according to the team at the National Institute for Cannabis Investors.

    Can You Really Earn 11,170% Returns By Investing in Cannabis?

    Investment industry experts will claim that the best time to invest in cannabis stocks was 2016 and 2017. In the leadup to nationwide legalization in Canada, Canadian cannabis company stocks surged several times, with some stocks experiencing trajectories similar to bitcoin and other cryptocurrencies.

    In 2018, many of these stocks plummeted, bringing investors back down to earth.

    The National Institute for Cannabis Investors, however, tries to dazzle you with stories of enormous investment returns from those who picked the right cannabis IPO at the right time. They describe how one investor earned a return of 11,170% by investing in a company the day of the IPO, for example.

    Like other “hot stock tips” style newsletters, the goal is to dazzle investors with stories of amazing returns. Everybody wants to put $100 in stock and watch it explode to $100,000. That’s the dream of any ordinary investor. The National Institute for Cannabis Investors, in their video and landing page, focus on stories like that in an effort to get you to sign up.

    The goal, of course, is to convince you to invest in four cannabis companies that are preparing to launch IPOs before January 31.

    Danny Brody has partnered with the National Institute for Cannabis Investors to share stories about each of these IPOs. The cannabis IPO expert describes how he told subscribers about companies like Emerald Health, for example. Shares of Emerald Health were sold at $0.40 on the day of the IPO. In January 2018, at the height of the cannabis market, the shares were worth $9.68, a gain of 2,320%.

    There are similar stories regarding the IPOs for companies like United Cannabis Corp and Cannabix Technologies. Again, the video cites the price of the share on the day of the IPO and compares it to the price of the share at the height of the cannabis market.

    This all boils down to one simple conclusion: if you bought shares of certain cannabis companies during their IPOs, then held onto those shares until the absolute height of the market in January 2018, then you would have earned returns of 2,000% to 5,000%. Now, the National Institute for Cannabis Investors wants you to subscribe to their newsletter to discover how you can earn similar returns.

    “This is the only time in history that you can get in for pennies a share and make tens of thousands of dollars,” explains the National Institute for Cannabis Investors video and sales page.

    What Will You Learn with a Subscription to Cannabis IPO Insider?

    Cannabis IPO Insider is an analysis newsletter for investors offered by the National Institute for Cannabis Investors. The newsletter claims to take a “white glove approach to cannabis investing and research.”

    “Our only goal is to bring you the insider insights you’ll need to get into the next billion-dollar IPO,” explains the sales video innocently.

    Every month, the Cannabis IPO Insider team selects two or three IPOs that they believe that the greatest upside. The team will research each of those IPOs and prepare a “Cannabis IPO Dossier” that includes all critical information about the company, including team information, profit predictions, buy and sell recommendations, and more.

    The newsletter also includes a video investor presentation for the company and other details of the forthcoming IPO.

    One of the key “hooks” to get you to sign up for the Cannabis IPO Insider is the company’s promise that four marijuana companies are set to go public before January 31.

    “And when it happens, it’s going to create the next round of marijuana millionaires,” explains the National Institute for Cannabis Investors sales video.

    What’s Included with Cannabis IPO Insider?

    A subscription to Cannabis IPO Insider comes with all of the following:

    • 2 email newsletters per month featuring cannabis IPO dossiers and video investor presentations as well as “insider information” about each of the companies preparing for the IPO
    • Four IPO dossiers and video investor presentations delivered today for cannabis companies preparing to launch multi-billion dollar IPOs before January 31, 2019
    • A Virtual Hot Seat where you can ask questions from the team at National Institute for Cannabis Investors, including questions about cannabis IPOs and the companies behind them; the organization claims “no question is out of bounds” during the Virtual Hot Seat
    • An IPO Action Plan prior to major cannabis IPOs; this action plan contains detailed instructions for how to participate in a particular IPO
    • Real-Time Profit Alerts notifying you when to buy and sell the new cannabis stocks you purchased during the IPO
    • Cell phone alerts, including text messages that arrive in your inbox when it’s time to cash out your profits and sell
    • Video reports “from the field” of the team exploring cannabis facilities, interviewing cannabis industry executives and conducting other on-the-ground research
    • Optional retreat upgrade, where certain members can pay to join the National Institute for Cannabis Investors on a retreat

    The core product here is the two email newsletters per month featuring information about upcoming cannabis IPOs and cannabis companies preparing to go public.

    Cannabis IPO Insider Pricing

    Cannabis IPO Insider is priced at $1,950 USD per year. There are no discounts available. You can only request a refund 12 months after you purchase your annual membership.

    You can buy Cannabis IPO Insider online through the online form at NICInvestors.com. Or, you can call the office directly at 866-298-7257 to order over the phone.

    The National Institute for Cannabis Investors seems to use sleazy marketing tactics to push its newsletter onto gullible investors. The organization claims that they’re limiting the newsletter to just 447 new subscribers, for example, and claims once those 447 spots are gone, they’re gone for good. This seems unlikely for an email newsletter, and it seems like the National Institute for Cannabis Investors is trying to create the illusion of scarcity.

    About the National Institute for Cannabis Investors

    The National Institute for Cannabis Investors is a Baltimore-based organization dedicated to exploring the world of cannabis for investors. The company offers a number of different email subscriptions and similar products catered to cannabis investors. Many of the organization’s products take a similar marketing approach: they convince investors that they can get rich quick by following the company’s stock tips today.

    Three individuals frequently appear in the organization’s marketing endeavors online, including Mike Ward (Founding Director), Danny Brody, and John Boehner. Yes, former Speaker of the House John Boehner is a key member of the company and has appeared in several videos advertising the company’s products.

    The National Institute for Cannabis Investors lists the following address as its headquarters:

    1125 North Charles Street
    Baltimore, MD 21201
    You can contact the company by phone at 866-298-7257.

    Conclusion: Should You Sign Up for the Cannabis IPO Insider?

    You should be skeptical any time an email newsletter promises to offer you five-digit percentage returns on your investment. Cannabis IPO Insider is a $2,000 per year newsletter that claims to give you hot stock tips regarding cannabis IPOs. Investors are told to expect unrealistically high gains of 2,000% to 5,000% by following the investment advice given in the newsletter.

    Despite the grandiose ROI claims, the newsletter does seem to give comprehensive information about upcoming cannabis industry IPOs, including four companies that are preparing to go public before January 31, 2019. The National Institute for Cannabis Investors claims to comprehensively research these companies and provide that information to investors.

    Ultimately, it’s up to you to decide if the National Institute for Cannabis Investors is worth $2,000 per year.